Hepatology International

, Volume 12, Issue 2, pp 167–173 | Cite as

Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis

  • Ka Wing Ma
  • Kenneth Siu Ho Chok
  • Wong Hoi She
  • Tan To Cheung
  • Albert Chi Yan Chan
  • Wing Chiu Dai
  • James Yan Yue Fung
  • Chung Mau Lo
Original Article



Uncommon primary hepatic malignancies such as intrahepatic cholangiocarcinoma (ICC) and hepatocholangiocarcinoma (HCC-CC) were generally considered contraindications for liver transplantation(LT), and studies comparing the efficacy of LT and resection (LR) for ICC/HCC-CC were scarce.


To compare the survival outcomes of ICC/HCC-CC patients treated by LT and LR in a propensity score-matched population.


This is a retrospective study from 1995 to 2015. Consecutive patients with the pathological diagnosis of ICC or HCC-CC in the surgical specimens were included. All patients had either hepatectomy or LT with curative intent. Factors associated with survival were identified with multivariate analysis using cox-regression model. Propensity score-matched analysis was performed.


There were 181 patients diagnosed to have ICC/HCC_CC. Nine patients received LT (all with incidental ICC/HCC-CC) and 172 received hepatectomy. The median follow-up period was 27.5 months. The median age was 60 years (range 3–86); Hepatitis B and C carrier status was found in 48.1 and 2.3% of the patients, respectively. The median tumor size was 6 cm and 71.3% of them had solitary tumor. Microvascular invasion was present in 47% of the patients. After propensity score matching, there were 54 (9 in LT and 45 in LR group) patients for analysis. Cox-regression analysis showed that early AJCC (7th) staging and LT were the independent factors associated with overall survival. Patients in the LT group had significantly better overall survival (5-year OS 77.8 vs 36.6%, log-rank p = 0.013).


ICC/HCC-CC are uncommon tumors with poor long-term oncological outcomes despite curative hepatectomy. Liver transplantation might be a better treatment option for patients with early ICC/HCC-CC.


Hepatocholangiocarcinoma Intrahepatic cholangiocarcinoma Resection Liver transplantation 


Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest in writing this article.


  1. 1.
    Aljiffry M, Abdulelah A, Walsh M, Peltekian K, Alwayn I, Molinari M. Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg. 2009;208(1):134–147.CrossRefPubMedGoogle Scholar
  2. 2.
    Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51(6):1–9.CrossRefGoogle Scholar
  3. 3.
    Aoki K, Takayasu K, Kawano T, Muramatsu Y, Moriyama N, Wakao F, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology. 1993;18(5):1090–1095.CrossRefPubMedGoogle Scholar
  4. 4.
    Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg. 1990;211(3):277–287.Google Scholar
  5. 5.
    Wachtel MS, Zhang Y, Xu T, Chiriva-Internati M, Frezza EE. Combined hepatocellular cholangiocarcinomas; analysis of a large database. Clin Med Pathol. 2008;1:43–47.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Casavilla FA, Marsh JW, Iwatsuki S, Todo S, Lee RG, Madariaga JR, et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg. 1997;185(5):429–436.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Pichlmayr R, Weimann A, Oldhafer KJ, Schlitt HJ, Klempnauer J, Bornscheuer A, et al. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg. 1995;19(6):807–813.CrossRefPubMedGoogle Scholar
  8. 8.
    Patkowski W, Stankiewicz R, Grąt M, Krasnodębski M, Kornasiewicz O, Krawczyk M. Poor outcomes after liver transplantation in patients with incidental cholangiocarcinoma irrespective of tumor localization. Transplant Proc. 2014;46(8):2774–2776.CrossRefPubMedGoogle Scholar
  9. 9.
    Chok KS, Ng KK, Cheung TT, Yuen WK, Poon RT, Lo CM, et al. An update on long-term outcome of curative hepatic resection for hepatocholangiocarcinoma. World J Surg. 2009;33(9):1916–1921.CrossRefPubMedGoogle Scholar
  10. 10.
    Jarnagin WR, Weber S, Tickoo SK, Koea JB, Obiekwe S, Fong Y, et al. Combined hepatocellular and cholangiocarcinoma. Cancer. 2002;94(7):2040–2046.CrossRefPubMedGoogle Scholar
  11. 11.
    Ma KW, Cheung TT, She WH, Chok KS, Chan AC, Ng IO, et al. The effect of wide resection margin in patients with intrahepatic cholangiocarcinoma: A single-center experience. Medicine (Baltimore). 2016;95(28):e4133.CrossRefGoogle Scholar
  12. 12.
    Ma KW, Chok KSH. Importance of surgical margin in the outcomes of hepatocholangiocarcinoma. World J Hepatol. 2017;9(13):635–641.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Chok KS, Ng KK, Cheung TT, Yuen WK, Poon RT, Lo CM, et al. An update on long-term outcome of curative hepatic resection for hepatocholangiocarcinoma. World J Surg. 2009;33(9):1916–1921.CrossRefPubMedGoogle Scholar
  14. 14.
    Gupta R, Togashi J, Akamatsu N, Sakamoto Y, Kokudo N. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review. Surg Today. 2017;47:1–10.CrossRefGoogle Scholar
  15. 15.
    Itoh S, Ikegami T, Yoshizumi T, Wang H, Takeishi K, Harimoto N, et al. Long-term outcome of living-donor liver transplantation for combined hepatocellular-cholangiocarcinoma. Anticancer Res. 2015;35(4):2475–2476.PubMedGoogle Scholar
  16. 16.
    Chan AC, Lo CM, Ng IO, Fan ST. Liver transplantation for combined hepatocellular cholangiocarcinoma. Asian J Surg. 2007;30(2):143–146.CrossRefPubMedGoogle Scholar
  17. 17.
    Sapisochin G, Facciuto M, Rubbia-Brandt L, Marti J, Mehta N, Yao FY, et al. Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment. Hepatology. 2016;64(4):1178–1188.CrossRefPubMedGoogle Scholar
  18. 18.
    Song S, Moon HH, Lee S, Kim TS, Shin M, Kim JM, et al. Comparison between resection and transplantation in combined hepatocellular and cholangiocarcinoma. Transplant Proc. 2013;45(8):3041–3046.CrossRefPubMedGoogle Scholar
  19. 19.
    Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center. Arch Surg. 2011;146(6):683–689.CrossRefPubMedGoogle Scholar
  20. 20.
    Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268–1289.CrossRefPubMedGoogle Scholar
  21. 21.
    Robles R, Figueras J, Turrión VS, Margarit C, Moya A, Varo E, et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma. Ann Surg. 2004;239(2):265.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Sapisochin G, Fidelman N, Roberts JP, Yao FY. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl. 2011;17(8):934–942.CrossRefPubMedGoogle Scholar
  23. 23.
    Facciuto ME, Singh MK, Lubezky N, Selim MA, Robinson D, Kim-Schluger L, et al. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation. Transplantation. 2015;99(1):151–157.CrossRefPubMedGoogle Scholar
  24. 24.
    Sapisochin G, de Lope CR, Gastaca M, de Urbina JO, López-Andujar R, Palacios F, et al. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study. Ann Surg. 2014;259(5):944–952.CrossRefPubMedGoogle Scholar
  25. 25.
    Vallin M, Sturm N, Lamblin G, Guillaud O, Hilleret MN, Hervieu V, et al. Unrecognized intrahepatic cholangiocarcinoma: an analysis of 993 adult cirrhotic liver explants. Clin Transplant. 2013;27(3):403–409.CrossRefPubMedGoogle Scholar
  26. 26.
    Galia M, Taibbi A, Marin D, Furlan A, Burgio MD, Agnello F, et al. Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? Diagn Interv Radiol. 2014;20(3):222.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Fowler KJ, Sheybani A, Parker RA III, Doherty S, Brunt E, Chapman WC. Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. Am J Roentgenol. 2013;201(2):332–339.CrossRefGoogle Scholar
  28. 28.
    Serra V, Tarantino G, Guidetti C, Aldrovandi S, Cuoghi M, Olivieri T, et al. Incidental intra-hepatic cholangiocarcinoma and hepatocholangiocarcinoma in liver transplantation: a single-center experience. Transplant Proc. 2016;48(2):366–369.CrossRefPubMedGoogle Scholar
  29. 29.
    Magistri P, Tarantino G, Serra V, Guidetti C, Ballarin R, Di Benedetto F. Liver transplantation and combined hepatocellular-cholangiocarcinoma: feasibility and outcomes. Dig Liver Dis. 2017;49(5):467–470.CrossRefPubMedGoogle Scholar
  30. 30.
    Park YH, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, et al. Long-term outcome of liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma. Transplant Proc. 2013;45(8):3038–3040.CrossRefPubMedGoogle Scholar
  31. 31.
    Tamandl D, Kaczirek K, Gruenberger B, Koelblinger C, Maresch J, Jakesz R, et al. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg. 2009;96(8):919–925.CrossRefPubMedGoogle Scholar
  32. 32.
    Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, et al. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2009;16(1):14–22.CrossRefPubMedGoogle Scholar
  33. 33.
    Nakagawa T, Kamiyama T, Kurauchi N, Matsushita M, Nakanishi K, Kamachi H, et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg. 2005;29(6):728–733.CrossRefPubMedGoogle Scholar
  34. 34.
    Ma KW, Cheung TT, She WH, Chok KS, Chan AC, Dai WC, et al. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer. World J Surg. 2017;12:1–12.CrossRefGoogle Scholar

Copyright information

© Asian Pacific Association for the Study of the Liver 2018

Authors and Affiliations

  • Ka Wing Ma
    • 1
  • Kenneth Siu Ho Chok
    • 1
    • 3
  • Wong Hoi She
    • 1
  • Tan To Cheung
    • 1
    • 3
  • Albert Chi Yan Chan
    • 1
    • 3
  • Wing Chiu Dai
    • 1
  • James Yan Yue Fung
    • 2
    • 3
  • Chung Mau Lo
    • 1
    • 3
  1. 1.Department of SurgeryThe University of Hong KongHong KongChina
  2. 2.Department of MedicineThe University of Hong KongHong KongChina
  3. 3.State Key Laboratory for Liver ResearchThe University of Hong KongHong KongChina

Personalised recommendations